Título: PROGNOSTIC SIGNIFICANCE OF CD30 EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW WITH META-ANALYSIS
Nome do Apresentador: Carla Isabelly RODRIGUES-FERNANDES
Categoria do Trabalho: Apresentação Oral de Pôster de Revisões Narrativas ou sistemáticas (PRN)
Área Temática: Oncologia
Resumo: Objective: To determine the frequency of CD30 expression in DLBCL and its potential for prognostic determination. Study Design: A systematic review was performed, followed by a quantitative meta-analysis to assess the frequency of CD30 expression with positivity cut-off values of >0% and >20%, and to determine its association with clinicopathological features and patients´ survival. Results: Using a cut-off value >0%, we observed that 3.5%-59.1% of the cases were considered positive for CD30. There was a significant association of the protein expression with a lower number of extra-nodal sites affected by the neoplasm, with Ann Arbor advanced stage, the absence of B-symptoms, the lack of MYC and BCL2 translocations, and a lower ECOG performance. Using a cut-off value >20%, we observed that 2.5%-36.7% of the cases were considered positive for CD30, being significantly associated with a lower number of extra-nodal sites affected by the neoplasm, Ann Arbor stages III/IV, non-GCB tumours, the lack of MYC and BCL2 translocations, and a lower ECOG value. Conclusion: Despite variations in the cut-off values used to determine CD30 positivity in DLBCL, the expression of this protein seems to be associated with a higher survival rate and better prognosis.
Autor 1: Carla Isabelly RODRIGUES-FERNANDES
E-mail 1: [email protected]
Autor 2: Lucas Guimarães Abreu
E-mail 2: [email protected]
Autor 3 : Danyel Elias da Cruz PEREZ
E-mail 3: [email protected]
Autor 4: Rogério de Oliveira GONDAK
E-mail 4: [email protected]
Autor 5: Peter A Brennan
E-mail 5: [email protected]
Autor 6: Pablo Agustin Vargas
E-mail 6: [email protected]
Autor 7: Felipe Paiva Fonseca
E-mail 7: [email protected]
Para baixar o aplicativo, escolha abaixo: